83 related articles for article (PubMed ID: 16886662)
1. The antitumor efficacy of calcitriol: preclinical studies.
Johnson CS; Muindi JR; Hershberger PA; Trump DL
Anticancer Res; 2006; 26(4A):2543-9. PubMed ID: 16886662
[TBL] [Abstract][Full Text] [Related]
2. Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling.
Bernardi RJ; Trump DL; Yu WD; McGuire TF; Hershberger PA; Johnson CS
Clin Cancer Res; 2001 Dec; 7(12):4164-73. PubMed ID: 11751517
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D compounds: clinical development as cancer therapy and prevention agents.
Trump DL; Muindi J; Fakih M; Yu WD; Johnson CS
Anticancer Res; 2006; 26(4A):2551-6. PubMed ID: 16886663
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.
Alagbala AA; Johnson CS; Trump DL; Posner GH; Foster BA
Oncology; 2006; 70(6):483-92. PubMed ID: 17237623
[TBL] [Abstract][Full Text] [Related]
5. Calcitriol (1,25-dihydroxycholecalciferol) potentiates activity of mitoxantrone/dexamethasone in an androgen independent prostate cancer model.
Ahmed S; Johnson CS; Rueger RM; Trump DL
J Urol; 2002 Aug; 168(2):756-61. PubMed ID: 12131364
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor activity of calcitriol: pre-clinical and clinical studies.
Trump DL; Hershberger PA; Bernardi RJ; Ahmed S; Muindi J; Fakih M; Yu WD; Johnson CS
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):519-26. PubMed ID: 15225831
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor: a potential target for intervention.
Johnson CS; Hershberger PA; Bernardi RJ; Mcguire TF; Trump DL
Urology; 2002 Sep; 60(3 Suppl 1):123-30; discussion 130-1. PubMed ID: 12231068
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D-related therapies in prostate cancer.
Johnson CS; Hershberger PA; Trump DL
Cancer Metastasis Rev; 2002; 21(2):147-58. PubMed ID: 12465754
[TBL] [Abstract][Full Text] [Related]
9. Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells.
Chung I; Wong MK; Flynn G; Yu WD; Johnson CS; Trump DL
Cancer Res; 2006 Sep; 66(17):8565-73. PubMed ID: 16951169
[TBL] [Abstract][Full Text] [Related]
10. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.
Ma Y; Yu WD; Kong RX; Trump DL; Johnson CS
Cancer Res; 2006 Aug; 66(16):8131-8. PubMed ID: 16912191
[TBL] [Abstract][Full Text] [Related]
11. RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects.
Yin Y; Ni J; Chen M; Guo Y; Yeh S
Clin Cancer Res; 2009 Jan; 15(1):190-200. PubMed ID: 19118046
[TBL] [Abstract][Full Text] [Related]
12. Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis.
Flynn G; Chung I; Yu WD; Romano M; Modzelewski RA; Johnson CS; Trump DL
Oncology; 2006; 70(6):447-57. PubMed ID: 17237620
[TBL] [Abstract][Full Text] [Related]
13. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
[TBL] [Abstract][Full Text] [Related]
14. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS
J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475
[TBL] [Abstract][Full Text] [Related]
15. Modulation of MAPK ERK1 and ERK2 in VDR-positive and -negative breast cancer cell lines.
Cordes T; Diesing D; Becker S; Diedrich K; Reichrath J; Friedrich M
Anticancer Res; 2006; 26(4A):2749-53. PubMed ID: 16886687
[TBL] [Abstract][Full Text] [Related]
16. Rhabdoid tumor growth is inhibited by flavopiridol.
Smith ME; Cimica V; Chinni S; Challagulla K; Mani S; Kalpana GV
Clin Cancer Res; 2008 Jan; 14(2):523-32. PubMed ID: 18223228
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C
Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone.
Yu WD; McElwain MC; Modzelewski RA; Russell DM; Smith DC; Trump DL; Johnson CS
J Natl Cancer Inst; 1998 Jan; 90(2):134-41. PubMed ID: 9450573
[TBL] [Abstract][Full Text] [Related]
19. CYP24A1 inhibition enhances the antitumor activity of calcitriol.
Muindi JR; Yu WD; Ma Y; Engler KL; Kong RX; Trump DL; Johnson CS
Endocrinology; 2010 Sep; 151(9):4301-12. PubMed ID: 20591973
[TBL] [Abstract][Full Text] [Related]
20. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
